We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+6.29%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$121B
AUM Growth
+$6.29B
Cap. Flow
+$257M
Cap. Flow %
0.21%
Top 10 Hldgs %
24.67%
Holding
4,045
New
183
Increased
1,650
Reduced
1,805
Closed
213

Sector Composition

Rank Sector Weight
1 Technology 15.49%
2 Financials 8.61%
3 Healthcare 8.48%
4 Industrials 6.86%
5 Consumer Discretionary 5.97%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LAZR
2176
DELISTED
Luminar Technologies
LAZR
$1.66M ﹤0.01%
16,090
+14,594
+976% +$1.38M
VCEL icon
2177
Vericel Corp
VCEL
$2.29B
$1.66M ﹤0.01%
44,137
+1,376
+3% +$45.2K
KLIC icon
2178
Kulicke & Soffa
KLIC
$5.01B
$1.65M ﹤0.01%
27,771
+4,245
+18% +$219K
SR icon
2179
Spire
SR
$4.89B
$1.65M ﹤0.01%
25,934
-220
-0.8% -$14.8K
BMBL icon
2180
Bumble
BMBL
$359M
$1.64M ﹤0.01%
97,558
+13,607
+16% +$235K
FDRR icon
2181
Fidelity Dividend ETF for Rising Rates
FDRR
$764M
$1.63M ﹤0.01%
39,134
+952
+2% +$38.8K
MMS icon
2182
Maximus
MMS
$2.94B
$1.63M ﹤0.01%
19,308
-6,434
-25% -$529K
EEMA icon
2183
iShares MSCI Emerging Markets Asia ETF
EEMA
$871M
$1.63M ﹤0.01%
24,817
+235
+1% +$15.4K
BPOP icon
2184
Popular Inc
BPOP
$11.3B
$1.63M ﹤0.01%
26,944
+2,213
+9% +$130K
BMI icon
2185
Badger Meter
BMI
$3.91B
$1.63M ﹤0.01%
11,050
+3,437
+45% +$473K
TEVA icon
2186
Teva Pharmaceuticals
TEVA
$42.6B
$1.63M ﹤0.01%
216,254
-21,351
-9% -$173K
SPDV icon
2187
AAM S&P 500 High Dividend Value ETF
SPDV
$104M
$1.62M ﹤0.01%
56,820
-1,537
-3% -$42.5K
HYI
2188
Western Asset High Yield Opportunity Fund Inc
HYI
$135M
$1.62M ﹤0.01%
137,469
-1,892
-1% -$22K
OMF icon
2189
OneMain Financial
OMF
$7.44B
$1.62M ﹤0.01%
36,968
-8,268
-18% -$323K
CRSP icon
2190
CRISPR Therapeutics
CRSP
$5.22B
$1.61M ﹤0.01%
28,767
-28,365
-50% -$1.61M
HMN icon
2191
Horace Mann Educators
HMN
$2.09B
$1.61M ﹤0.01%
54,412
+18,287
+51% +$580K
DNL icon
2192
WisdomTree Global ex-U.S. Quality Growth Fund
DNL
$505M
$1.61M ﹤0.01%
45,034
+15,827
+54% +$564K
IAS
2193
DELISTED
Integral Ad Science
IAS
$1.61M ﹤0.01%
+89,389
New +$1.51M
VLU icon
2194
State Street SPDR S&P 1500 Value Tilt ETF
VLU
$784M
$1.61M ﹤0.01%
10,817
+624
+6% +$89.2K
KKR.PRC
2195
DELISTED
KKR & Co. Inc. 6.00% Series C Mandatory Convertible Preferred Stock
KKR.PRC
$1.61M ﹤0.01%
24,304
-187
-0.8% -$11.8K
LMAT icon
2196
LeMaitre Vascular
LMAT
$1.87B
$1.61M ﹤0.01%
23,860
+2,779
+13% +$170K
LGTY
2197
DELISTED
Logility Supply Chain Solutions, Inc. Common Stock
LGTY
$1.59M ﹤0.01%
151,622
+4,520
+3% +$54.5K
GTY
2198
Getty Realty Corp
GTY
$2.04B
$1.59M ﹤0.01%
46,938
-2,615
-5% -$88.9K
FBNC icon
2199
First Bancorp
FBNC
$2.72B
$1.58M ﹤0.01%
53,122
+1,476
+3% +$46.7K
PD icon
2200
PagerDuty
PD
$932M
$1.58M ﹤0.01%
70,179
+432
+0.6% +$12K

Similar funds

Raymond James & Associates's Q2 2023 Portfolio in Review

As of Q2 2023, Raymond James & Associates held 4,045 positions worth $121B, up 5.5% from $115B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Raymond James & Associates's Q2 2023 filing shows 183 new, 1,650 increased, 1,805 reduced and 213 closed positions. Its largest new stake was Choice Hotels: 212,259 shares worth $24.9M. The largest sale was iShares MSCI USA Min Vol Factor ETF, an estimated $562M.

By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Financials and Healthcare.

  • Raymond James & Associates's largest Q2 2023 buy was Choice Hotels: 212,259 shares worth $24.9M.
  • Raymond James & Associates added most to iShares Core US Aggregate Bond ETF in Q2 2023, an estimated $753M increase.
  • Raymond James & Associates's biggest Q2 2023 reduction was iShares MSCI USA Min Vol Factor ETF, cutting an estimated $562M.
  • Raymond James & Associates fully exited ABB Ltd in Q2 2023, selling an estimated $17.1M.
  • Raymond James & Associates's ten largest holdings make up 25% of its $121B portfolio in Q2 2023.
  • Raymond James & Associates opened 183 new positions and closed 213 in Q2 2023.
  • Raymond James & Associates's portfolio value rose 5.5% quarter-over-quarter to $121B.

Based on Raymond James & Associates's 13F filing for Q2 2023, filed 25 Jul 2023.